[1]
|
Kopp, J.B., Anders, H.-J., Susztak, K., Podestà, M.A., Remuzzi, G., Hildebrandt, F. and Romagnani, P. (2020) Podocytopathies. Nature Reviews Disease Primers, 6, Article No. 68. https://doi.org/10.1038/s41572-020-0196-7
|
[2]
|
安梦丽, 何平. 足细胞损伤的机制及与肾小球疾病的关系研究进展[J]. 中国临床研究, 2018, 31(10): 1427-1431.
|
[3]
|
李卫国, 李宇宁. 足细胞对损伤的反应[J]. 临床儿科杂志, 2012, 30(11): 1091-1094.
|
[4]
|
Mundel, P. and Shankland, S.J. (2002) Podocyte Biology and Response to Injury. Journal of the American Society of Nephrology, 13, 3005-3015. https://doi.org/10.1097/01.ASN.0000039661.06947.FD
|
[5]
|
Vignesh, P., Rawat, A., Sharma, M., et al. (2017) Complement in Autoimmune Diseases. Clinica Chimica Acta, 465, 123-130. https://doi.org/10.1016/j.cca.2016.12.017
|
[6]
|
Józsi, M., Schneider, A.E., et al. (2019) Complement Factor H Family Proteins in Their Non-Canonical Role as Modulators of Cellular Functions. Seminars in Cell & Developmental Biology, 85, 122-131. https://doi.org/10.1016/j.semcdb.2017.12.018
|
[7]
|
Ferreiraa, V.P., Pangburnb, M.K. and Cortésa, C. (2010) Complement Control Protein Factor H: The Good, the Bad, and the Inadequat. Molecular Immunology, 47, 2187-2197. https://doi.org/10.1016/j.molimm.2010.05.007
|
[8]
|
Skerka, C., Chen, Q., Fremeaux-Bacchi, V., et al. (2013) Complement Factor H Related Proteins (CFHRS). Molecular Immunology, 56, 170-180. https://doi.org/10.1016/j.molimm.2013.06.001
|
[9]
|
Hannan, J.P., Laskowski, J., Thurman, J.M., et al. (2016) Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions. PLOS ONE, 11, e0166200. https://doi.org/10.1371/journal.pone.0166200
|
[10]
|
Kerjaschki, D., Schulze, M. and Binder, S. (1989) Transcellular Transport and Membrane Insertion of the C5b-9 Membrane Attack Complex of Complement by Glomerular Epithelial Cells in Experimental Membranous Nephropathy. The Journal of Immunology, 143, 546-552. https://doi.org/10.4049/jimmunol.143.2.546
|
[11]
|
Leenaerts, P.L., Hall, B.M. and Van Damme, B.J. (1995) Active Heymann Nephritis in Complement Component C6 Deficient Rats. Kidney International, 47, 1604-1614. https://doi.org/10.1038/ki.1995.224
|
[12]
|
Ronco, P. and Debiec, H. (2017) A Podocyte View of Membranous Nephropathy: From Heymann Nephritis to the Childhood Human Disease. Pflügers Archiv, 469, 997-1005. https://doi.org/10.1007/s00424-017-2007-x
|
[13]
|
Hofer, J., Janecke, A.R., Zimmerhackl, L.B., et al. (2013) Complement Factor H-Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology, 8, 407-415. https://doi.org/10.2215/CJN.01260212
|
[14]
|
Dragon-Durey, M.A., Blanc, C., Marliot, F., et al. (2009) The High Frequency of Complement Factor H Related CFHR1 Gene Deletion Is Restricted to Specific Subgroups of Patients with Atypical Haemolytic Uraemic Syndrome. Journal of Medical Genetics, 46, 447-450. https://doi.org/10.1136/jmg.2008.064766
|
[15]
|
Eyler, S.J., Meyer, N.C., Zhang, Y., et al. (2013) A Novel Hybrid CFHR1/CFH Gene Causes Atypical Hemolytic Uremic Syndrome. Pediatric Nephrology, 28, 2221-2225. https://doi.org/10.1007/s00467-013-2560-2
|
[16]
|
朱旭, 李丹丹, 邱玲. 补体因子H相关蛋白1的研究进展[J]. 临床检验杂志, 2020, 38(4): 280-282.
|
[17]
|
Beck, L.H., Bonegio, R.G., Lambeau, G., Beck, D.M., Powell, D.W., Cummins, T.D., et al. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21. https://doi.org/10.1056/NEJMoa0810457
|
[18]
|
Fresquet, M., Jowitt, T.A., Gummadova, J., Collins, R., O’Cualain, R., McKenzie, E.A., et al. (2015) Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 26, 302-313. https://doi.org/10.1681/ASN.2014050502
|
[19]
|
Zhu, P., Zhou, F.D., Wang, S.X., et al. (2015) Increasing Frequency of Idiopathic Membranous Nephropathy in Primary Glomerular Disease: A 10-Year Renal Biopsy Study from a Single Chinese Nephrology Centre. Nephrology (Carlton), 20, 560-566. https://doi.org/10.1111/nep.12542
|
[20]
|
Thurman, J.M. and Nester, C.M. (2016) All Things Complement. Clinical Journal of the American Society of Nephrology, 11, 1856-1866. https://doi.org/10.2215/CJN.01710216
|
[21]
|
Keir, L.S., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., et al. (2017) VEGF Regulates Local Inhibitory Complement Proteins in the Eye and Kidney. Journal of Clinical Investigation, 127, 199-214. https://doi.org/10.1172/JCI86418
|
[22]
|
Cserhalmi, M., Papp, A., Brandus, B., et al. (2019) Regulation of Regulators: Role of the Complement Factor H-Related Proteins. Seminars in Immunology, 45, Article ID: 101341. https://doi.org/10.1016/j.smim.2019.101341
|
[23]
|
Zhu, L., Zhai, Y.L., Wang, F.M., et al. (2015) Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy. American Society of Nephrology, 26, 1195-1204. https://doi.org/10.1681/ASN.2014010096
|
[24]
|
Xie, J., Kiryluk, K., Li, Y., et al. (2016) Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese. American Society of Nephrology, 27, 3187-3194. https://doi.org/10.1681/ASN.2015111210
|
[25]
|
Jennifer, C., Haas, M., Reich, H.N., et al. (2017) Ig A Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 677-686. https://doi.org/10.2215/CJN.07420716
|
[26]
|
郑笑, 张艳君, 杨淑芬, 等. 补体因子H和补体因子H相关蛋白1、2、3和5与IgA肾病的关联性[J]. 实用医学杂志, 2018, 34(22): 3727-3730.
|
[27]
|
Gharavi, A.G., Kiryluk, K., Choi, M., et al. (2011) Genome-Wide Association Study Identifies Susceptibility Loci for IgA Nephropathy. Nature Genetics, 43, 321-327. https://doi.org/10.1038/ng.787
|